Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study

Autor: Zürcher, Kathrin, Egger, Matthias, Fenner, Lukas, Ballif, Marie, Chammartin, Frédérique, Gagneux, Sebastien, Borrell, Sonia, Reinhard, Miriam, Boettger, Erik C., Keller, Peter, Hömke, Rico, Abimiku, Alash'le, Ezati, Nicholas, Yotebieng, Marcel, Wenzi, Landry, Tabala, Martine, Cox, Helen, Rockwood, Neesha, Warren, Robin, Streicher, Elizabeth, Wilkinson, Robert J., Carter, E. Jane, Diero, Lameck, Collantes, Jimena, Zamudio, Carlos, Huebner, Robin, Sohn, Annette, Avihingsanon, Anchalee, Petersen, Tor, Kawkitinarong, Kamon, Kasipong, Naruporn, Gnokoro, Joachim, N'Guessan, Kouassi, Marcy, Olivier, Keller, Peter M, Carter, E Jane, Wilkinson, Robert J, Abimiku, Alash'le G, Böttger, Erik C ^*

Publikováno v: In The Lancet Infectious Diseases March 2019 19(3):298-307

The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.

Autor: Ezati, Nicholas¹ ezatinick@yahoo.co.uk, Lukoye, Deus¹ deuslukoye@gmail.com, Wampande, Eddie M.^2,3 ewampande@yahoo.co.uk, Musisi, Kenneth⁴ kenmusisi@yahoo.co.uk, Kasule, George W.⁴ kasulegw@gmail.com, Cobelens, Frank G. J.⁵ f.cobelens@aighd.org, Kateete, David P.² davidateete@gmail.com, Joloba, Moses L.^2,4 mlj10@case.edu

Publikováno v: BMC Infectious Diseases. 2014, Vol. 14 Issue 1, p853-868. 16p. 4 Charts, 1 Map.

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria.

Autor: Aliyu, Gambo, El-Kamary, Samer S., Abimiku, Alash'le, Ezati, Nicholas, Mosunmola, Iwakun, Hungerford, Laura, Brown, Clayton, Tracy, Kathleen J., Obasanya, Joshua, Blattner, William

Publikováno v: Tuberculosis Research & Treatment; 2013, p1-9, 9p, 3 Charts

Implementing quality assurance for laboratory-based and point-of-care HIV testing in Nigeria.

Autor: Abubakar A; National External Quality Assessment Laboratory, Saye Zaria, Kaduna State, Nigeria.; Institute of Human Virology, Maina Court, Plot 252, Herbert Macaulay Way CBD, Abuja, Nigeria., Peters S; Institute of Human Virology, Maina Court, Plot 252, Herbert Macaulay Way CBD, Abuja, Nigeria., Balogun O; Institute of Human Virology, Maina Court, Plot 252, Herbert Macaulay Way CBD, Abuja, Nigeria., Osawe S; Institute of Human Virology, Maina Court, Plot 252, Herbert Macaulay Way CBD, Abuja, Nigeria.; Plateau State Human Virology Research Center, Plateau Hospital, Jos, Nigeria., Mamman I; Institute of Human Virology, Maina Court, Plot 252, Herbert Macaulay Way CBD, Abuja, Nigeria.; Plateau State Human Virology Research Center, Plateau Hospital, Jos, Nigeria., Barde J; National External Quality Assessment Laboratory, Saye Zaria, Kaduna State, Nigeria.; University of Maryland School of Medicine, Baltimore, Maryland, United States., Ojo E; Family Health International (FHI 360), Garki Abuja, Nigeria., Ezati N; Institute of Human Virology, Maina Court, Plot 252, Herbert Macaulay Way CBD, Abuja, Nigeria.; National Tuberculosis and Leprosy Training Center, Saye, Zaria, Kaduna State, Nigeria., Bango J; HIV/AIDS Division, Federal Ministry of Health, Edo House Abuja, Nigeria., Ngige E; HIV/AIDS Division, Federal Ministry of Health, Edo House Abuja, Nigeria., Emeribe A; Medical Laboratory Science Council of Nigeria, Durumi, Abuja, Nigeria., Abimiku A; Institute of Human Virology, Maina Court, Plot 252, Herbert Macaulay Way CBD, Abuja, Nigeria.; University of Maryland School of Medicine, Baltimore, Maryland, United States.

Publikováno v: African journal of laboratory medicine [Afr J Lab Med] 2016 Oct 17; Vol. 5 (2), pp. 455. Date of Electronic Publication: 2016 Oct 17 (Print Publication: 2016).